Search Tag: a clinical-stage drug platform company

Executive Health Management

Annovis Bio Appoints Henry Hagopian III as Chief Financial Officer

2022 29 Aug

Annovis Bio, Inc., a clinical-stage drug platform company addressing neurodegenerative diseases, announced the appointment of Henry Hagopian III as Chief Financial Officer, effective immediately.  Mr. Hagopian comes to Annovis with 30 years of finance and accounting experience, including 15 years of increasing responsibility at Organogenesis, a leading... Read more